ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Artiva Biotherapeutics, Inc.
2.44
+0.0700
2.95%
盤後:
2.44
0.0000
0.00%
16:05 EDT
成交量:
24.45萬
成交額:
60.04萬
市值:
5,944.60萬
市盈率:
-0.42
高:
2.56
開:
2.38
低:
2.29
收:
2.37
資料載入中...
總覽
公司
新聞
公告
Artiva Biotherapeutics, Inc.盤中異動 大幅拉昇5.25%報12.43美元
市场透视
·
2024-11-26
Artiva Biotherapeutics, Inc.盤中異動 早盤股價大漲5.76%報11.85美元
市场透视
·
2024-11-25
Artiva Biotherapeutics, Inc.盤中異動 早盤股價大漲5.84%報11.51美元
市场透视
·
2024-11-22
Artiva Biotherapeutics, Inc.盤中異動 股價大漲5.11%報11.52美元
市场透视
·
2024-11-22
Artiva Biotherapeutics, Inc.盤中異動 早盤急速上漲6.94%
市场透视
·
2024-11-19
Artiva Biotherapeutics, Inc.2024財年第三財季實現淨利潤-17.47百萬美元,同比減少254.88%
市场透视
·
2024-11-19
Artiva Biotherapeutics, Inc.盤中異動 下午盤股價大漲5.47%報10.61美元
市场透视
·
2024-11-19
Artiva Biotherapeutics, Inc.盤中異動 股價大跌5.13%
市场透视
·
2024-11-14
Artiva Biotherapeutics, Inc.盤中異動 下午盤快速跳水5.01%報12.71美元
市场透视
·
2024-11-13
Artiva Biotherapeutics, Inc.盤中異動 急速下跌5.73%報13.16美元
市场透视
·
2024-11-09
Artiva Biotherapeutics, Inc.盤中異動 早盤快速拉昇7.05%報15.49美元
市场透视
·
2024-11-07
Artiva Biotherapeutics, Inc.盤中異動 快速拉昇5.04%報12.50美元
市场透视
·
2024-11-06
Artiva Biotherapeutics, Inc.盤中異動 股價大漲5.41%
市场透视
·
2024-11-05
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ARTV/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":2.44,"timestamp":1746216000000,"preClose":2.37,"halted":0,"volume":244466,"hourTrading":{"tag":"盘后","latestPrice":2.44,"preClose":2.44,"latestTime":"16:05 EDT","volume":1246,"amount":3040.24,"timestamp":1746216305972},"delay":0,"floatShares":4396863,"shares":24363119,"eps":-5.806365,"marketStatus":"盤後交易","change":0.07,"latestTime":"05-02 16:13:41 EDT","open":2.38,"high":2.56,"low":2.29,"amount":600422.4667,"amplitude":0.113924,"askPrice":2.49,"askSize":100,"bidPrice":2.34,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-5.806365,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1746230400000},"marketStatusCode":4,"adr":0,"listingDate":1721361600000,"exchange":"NASDAQ","adjPreClose":2.37,"preHourTrading":{"tag":"盘前","latestPrice":2.32,"preClose":2.37,"latestTime":"09:16 EDT","volume":1,"amount":2.32,"timestamp":1746191808230},"postHourTrading":{"tag":"盘后","latestPrice":2.44,"preClose":2.44,"latestTime":"16:05 EDT","volume":1246,"amount":3040.24,"timestamp":1746216305972},"volumeRatio":1.56053},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","floatShares":4396863,"roa":"-26.72%","roe":"-54.24%","lyrEps":-5.806365,"volumeRatio":1.56053,"shares":24363119,"dividePrice":0,"high":2.56,"amplitude":0.113924,"preClose":2.37,"low":2.29,"week52Low":1.78,"pbRate":"0.32","psRate":"236.84","week52High":17.31,"institutionHeld":0,"latestPrice":2.44,"committee":-0.818182,"eps":-5.806365,"divideRate":0,"volume":244466,"delay":0,"ttmEps":-5.806365,"open":2.38,"prevYearClose":10.08,"prevWeekClose":2.47,"prevMonthClose":2.39,"prevQuarterClose":3,"fiveDayClose":2.47,"twentyDayClose":2.54,"sixtyDayClose":4.88},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARTV\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2486888612","title":"Artiva Biotherapeutics, Inc.盤中異動 大幅拉昇5.25%報12.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486888612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486888612?lang=zh_tw&edition=fundamental","pubTime":"2024-11-26 23:49","pubTimestamp":1732636176,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时49分,Artiva Biotherapeutics, Inc.股票出现异动,股价大幅上涨5.25%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Poseida Therapeutics, Inc.、Protagenic Therapeutics, Inc.、Ventyx Biosciences, Inc.涨幅较大,Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃,换手率分别为35.59%、23.33%、21.12%,振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.、Fate Therapeutics, Inc.,振幅分别为85.82%、42.94%、34.09%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126234936971a8acd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126234936971a8acd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2486403547","title":"Artiva Biotherapeutics, Inc.盤中異動 早盤股價大漲5.76%報11.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486403547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486403547?lang=zh_tw&edition=fundamental","pubTime":"2024-11-25 23:11","pubTimestamp":1732547518,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时11分,Artiva Biotherapeutics, Inc.股票出现异动,股价大幅拉升5.76%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.82%。其相关个股中,Alpha Tau Medical Ltd C/Wts 、Ocean Biomedical Inc C/Wts 14/02/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为97.99%、95.60%、55.92%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Apollomics Inc C/Wts 01/04/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为62.44%、55.45%、47.19%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112523115898e446e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112523115898e446e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2485267335","title":"Artiva Biotherapeutics, Inc.盤中異動 早盤股價大漲5.84%報11.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485267335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485267335?lang=zh_tw&edition=fundamental","pubTime":"2024-11-22 23:17","pubTimestamp":1732288636,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时17分,Artiva Biotherapeutics, Inc.股票出现波动,股价大幅上涨5.84%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.72%。其相关个股中,Replimune Group, Inc.、Virpax Pharmaceuticals, Inc.、奥麦罗制药涨幅较大,Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃,换手率分别为1551.97%、109.07%、81.35%,振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为55.96%、45.86%、38.10%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122231716abd7a6a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122231716abd7a6a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2485881410","title":"Artiva Biotherapeutics, Inc.盤中異動 股價大漲5.11%報11.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485881410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485881410?lang=zh_tw&edition=fundamental","pubTime":"2024-11-22 01:12","pubTimestamp":1732209171,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时12分,Artiva Biotherapeutics, Inc.股票出现波动,股价急速上涨5.11%。截至发稿,该股报11.52美元/股,成交量9016股,换手率0.04%,振幅4.74%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122011251a24bbb4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122011251a24bbb4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2484925542","title":"Artiva Biotherapeutics, Inc.盤中異動 早盤急速上漲6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484925542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484925542?lang=zh_tw&edition=fundamental","pubTime":"2024-11-19 22:46","pubTimestamp":1732027597,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时46分,Artiva Biotherapeutics, Inc.股票出现异动,股价大幅拉升6.94%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.62%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Dermata Therapeutics Inc C/Wts 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃,换手率分别为669.74%、87.32%、73.65%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tff Pharmaceuticals, Inc.,振幅分别为70.00%、52.14%、45.03%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922463898e43843&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922463898e43843&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2484913703","title":"Artiva Biotherapeutics, Inc.2024財年第三財季實現淨利潤-17.47百萬美元,同比減少254.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484913703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484913703?lang=zh_tw&edition=fundamental","pubTime":"2024-11-19 18:00","pubTimestamp":1732010430,"startTime":"0","endTime":"0","summary":"11月19日,Artiva Biotherapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-17.47百万美元,同比减少254.88%;其中营业收入为0.00美元,每股基本收益为-0.72美元。从资产负债表来看,Artiva Biotherapeutics, Inc.总负债24.60百万美元,其中短期债务3.73百万美元,资产负债比为0.10,流动比率为0.12。机构评级:截至2024年11月19日,当前有4家机构对Artiva Biotherapeutics, Inc.目标价做出预测,其中目标均价为21.25美元,其中最低目标价为18.00美元,最高目标价为23.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180150a24562b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180150a24562b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV"],"gpt_icon":0},{"id":"2484988023","title":"Artiva Biotherapeutics, Inc.盤中異動 下午盤股價大漲5.47%報10.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484988023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484988023?lang=zh_tw&edition=fundamental","pubTime":"2024-11-19 03:48","pubTimestamp":1731959328,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日03时48分,Artiva Biotherapeutics, Inc.股票出现异动,股价大幅上涨5.47%。截至发稿,该股报10.61美元/股,成交量1.8364万股,换手率0.08%,振幅5.51%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119034848a243b022&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119034848a243b022&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2483680209","title":"Artiva Biotherapeutics, Inc.盤中異動 股價大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483680209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483680209?lang=zh_tw&edition=fundamental","pubTime":"2024-11-14 22:56","pubTimestamp":1731596206,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时56分,Artiva Biotherapeutics, Inc.股票出现波动,股价急速跳水5.13%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.54%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Pulmatrix, Inc.涨幅较大,Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为2009.64%、34.57%、32.04%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp C/Wts 24/02/2025、Pulmatrix, Inc.,振幅分别为75.00%、44.00%、38.76%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114225646971a693d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114225646971a693d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2483030858","title":"Artiva Biotherapeutics, Inc.盤中異動 下午盤快速跳水5.01%報12.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483030858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483030858?lang=zh_tw&edition=fundamental","pubTime":"2024-11-13 02:42","pubTimestamp":1731436975,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日02时42分,Artiva Biotherapeutics, Inc.股票出现波动,股价急速跳水5.01%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.83%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Genprex, Inc.、美第奇新星生物技术涨幅较大,Genprex, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为543.34%、432.00%、232.77%,振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Geovax Labs Inc C/Wts 29/09/2025、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ,振幅分别为209.30%、105.45%、86.87%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113024255abbac420&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113024255abbac420&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2482817634","title":"Artiva Biotherapeutics, Inc.盤中異動 急速下跌5.73%報13.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482817634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482817634?lang=zh_tw&edition=fundamental","pubTime":"2024-11-09 00:31","pubTimestamp":1731083511,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日00时31分,Artiva Biotherapeutics, Inc.股票出现波动,股价快速下跌5.73%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.77%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Elevai Labs, Inc.、Lipella Pharmaceuticals Inc.、Matinas Biopharma Holdings, Inc.较为活跃,换手率分别为650.61%、62.15%、53.34%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为102.22%、87.00%、52.00%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109003151abae8575&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109003151abae8575&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2481872461","title":"Artiva Biotherapeutics, Inc.盤中異動 早盤快速拉昇7.05%報15.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481872461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481872461?lang=zh_tw&edition=fundamental","pubTime":"2024-11-07 23:44","pubTimestamp":1730994271,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时44分,Artiva Biotherapeutics, Inc.股票出现波动,股价急速拉升7.05%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,Ensysce Biosciences, Inc.、Celularity Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大,Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为729.06%、154.97%、94.22%,振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.,振幅分别为84.83%、68.89%、57.79%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234432abaa9967&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234432abaa9967&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2481981613","title":"Artiva Biotherapeutics, Inc.盤中異動 快速拉昇5.04%報12.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481981613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481981613?lang=zh_tw&edition=fundamental","pubTime":"2024-11-06 23:08","pubTimestamp":1730905725,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时08分,Artiva Biotherapeutics, Inc.股票出现异动,股价急速上涨5.04%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.42%。其相关个股中,Sonnet Biotherapeutics Holdings, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃,换手率分别为1587.89%、179.08%、81.04%,振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Protagenic Therapeutics, Inc.、Neuraxis, Inc.,振幅分别为73.16%、24.63%、23.51%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106230845971a4d0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106230845971a4d0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2481553946","title":"Artiva Biotherapeutics, Inc.盤中異動 股價大漲5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481553946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481553946?lang=zh_tw&edition=fundamental","pubTime":"2024-11-05 03:21","pubTimestamp":1730748076,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日03时21分,Artiva Biotherapeutics, Inc.股票出现异动,股价快速拉升5.41%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.46%。其相关个股中,Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大,Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃,换手率分别为450.53%、284.37%、100.31%,振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.,振幅分别为52.25%、45.56%、45.39%。Artiva Biotherapeutics, Inc.公司简介:Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105032116a215c0d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105032116a215c0d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":73,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTV\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1735617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARTV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARTV","date":"2025-05-01","current":-0.890702,"percent":0.956757,"low":-11.820615,"twenty":-9.371365,"median":-4.272117,"eighty":-1.589533,"high":-0.685729,"avg":-5.227046,"sd":3.601764,"marketCap":58227854},"quantilePoints":[{"date":"2024-08-02","current":-10.391793,"twenty":-10.391793,"median":-10.391793,"eighty":-10.391793,"marketCap":269833291},{"date":"2024-08-09","current":-9.862789,"twenty":-10.391793,"median":-10.042112,"eighty":-9.943484,"marketCap":256097171},{"date":"2024-08-16","current":-10.185571,"twenty":-10.248334,"median":-10.131774,"eighty":-9.95245,"marketCap":264478532},{"date":"2024-08-23","current":-8.939273,"twenty":-10.248334,"median":-10.051078,"eighty":-9.342751,"marketCap":232117163},{"date":"2024-08-30","current":-8.088598,"twenty":-10.185571,"median":-9.943484,"eighty":-9.046867,"marketCap":263081639},{"date":"2024-09-06","current":-8.893463,"twenty":-10.142533,"median":-9.800025,"eighty":-8.930111,"marketCap":289259885},{"date":"2024-09-13","current":-8.019798,"twenty":-10.131774,"median":-9.459311,"eighty":-8.763533,"marketCap":260843926},{"date":"2024-09-20","current":-8.759053,"twenty":-10.07439,"median":-9.028935,"eighty":-8.450238,"marketCap":284888199},{"date":"2024-09-27","current":-9.946342,"twenty":-10.07439,"median":-9.323455,"eighty":-8.581333,"marketCap":323504758},{"date":"2024-10-04","current":-11.499524,"twenty":-10.277026,"median":-9.57298,"eighty":-8.727691,"marketCap":374022017},{"date":"2024-10-11","current":-10.566121,"twenty":-10.505561,"median":-9.728296,"eighty":-8.794895,"marketCap":343663087},{"date":"2024-10-18","current":-9.543111,"twenty":-10.587029,"median":-9.800025,"eighty":-8.869568,"marketCap":310389700},{"date":"2024-10-25","current":-7.586699,"twenty":-10.505561,"median":-9.574426,"eighty":-8.581333,"marketCap":246757383},{"date":"2024-10-31","current":-7.579232,"twenty":-10.485041,"median":-9.464706,"eighty":-8.226879,"marketCap":246514511},{"date":"2024-11-08","current":-10.424244,"twenty":-10.485041,"median":-9.3863,"eighty":-8.226879,"marketCap":339048530},{"date":"2024-11-15","current":-4.166082,"twenty":-10.46953,"median":-9.378833,"eighty":-8.149728,"marketCap":255280837},{"date":"2024-11-22","current":-4.310765,"twenty":-10.439178,"median":-9.30416,"eighty":-7.969021,"marketCap":264146442},{"date":"2024-11-29","current":-5.065892,"twenty":-10.411264,"median":-9.046867,"eighty":-7.81669,"marketCap":310417611},{"date":"2024-12-06","current":-4.598149,"twenty":-10.334409,"median":-8.970887,"eighty":-7.365669,"marketCap":281756204},{"date":"2024-12-13","current":-4.233469,"twenty":-10.223229,"median":-8.939273,"eighty":-5.058757,"marketCap":259410023},{"date":"2024-12-20","current":-3.963922,"twenty":-10.173512,"median":-8.885996,"eighty":-4.852633,"marketCap":242893280},{"date":"2024-12-27","current":-4.17401,"twenty":-10.150694,"median":-8.781454,"eighty":-4.667914,"marketCap":255766623},{"date":"2025-01-03","current":-3.95203,"twenty":-10.131774,"median":-8.549971,"eighty":-4.598149,"marketCap":242164600},{"date":"2025-01-10","current":-4.066984,"twenty":-10.131774,"median":-8.396892,"eighty":-4.398368,"marketCap":249208505},{"date":"2025-01-17","current":-2.687539,"twenty":-10.07439,"median":-8.17661,"eighty":-4.337719,"marketCap":164681643},{"date":"2025-01-24","current":-2.477451,"twenty":-10.049285,"median":-8.109405,"eighty":-4.224748,"marketCap":151808300},{"date":"2025-01-31","current":-2.140518,"twenty":-10.011532,"median":-8.012331,"eighty":-4.193829,"marketCap":131162371},{"date":"2025-02-07","current":-1.823404,"twenty":-9.967928,"median":-7.881014,"eighty":-4.108209,"marketCap":111730908},{"date":"2025-02-14","current":-1.589533,"twenty":-9.948785,"median":-7.698708,"eighty":-3.978192,"marketCap":97400205},{"date":"2025-02-21","current":-1.502326,"twenty":-9.945199,"median":-7.508293,"eighty":-3.804572,"marketCap":92056553},{"date":"2025-02-28","current":-1.478543,"twenty":-9.911206,"median":-5.18038,"eighty":-2.77871,"marketCap":90599193},{"date":"2025-03-07","current":-2.0216,"twenty":-9.837683,"median":-5.059946,"eighty":-2.521847,"marketCap":123875572},{"date":"2025-03-14","current":-2.219796,"twenty":-9.795827,"median":-4.998506,"eighty":-2.343471,"marketCap":136020236},{"date":"2025-03-21","current":-1.601424,"twenty":-9.736345,"median":-4.76067,"eighty":-2.165887,"marketCap":98128885},{"date":"2025-03-28","current":-1.319282,"twenty":-9.624289,"median":-4.665536,"eighty":-2.054897,"marketCap":86245441},{"date":"2025-04-04","current":-0.946604,"twenty":-9.574715,"median":-4.606077,"eighty":-1.965312,"marketCap":61882322},{"date":"2025-04-11","current":-0.685729,"twenty":-9.561032,"median":-4.439593,"eighty":-1.797242,"marketCap":44828138},{"date":"2025-04-17","current":-0.857161,"twenty":-9.511749,"median":-4.37617,"eighty":-1.744126,"marketCap":56035173},{"date":"2025-04-25","current":-0.913063,"twenty":-9.383313,"median":-4.344458,"eighty":-1.606181,"marketCap":59689641},{"date":"2025-05-01","current":-0.890702,"twenty":-9.371365,"median":-4.272117,"eighty":-1.589533,"marketCap":58227854}],"updateTime":1746216821835}}}